Kuppusamy Karthik
Officer at DGX
- Sold, on record
- $5.2M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jun 4, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DGXQUEST DIAGNOSTICS INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice DGXNoticeApr 2, 2025 2025
Filed to sell 2,555 shares ($434k)
Kuppusamy Karthik, Officer
10b5-1 plan1.4x usual sizeFiling
- 2 Form 4 sale DGXRoutineApr 2, 2025 same day
Sold 2,555 shares at $170.00 ($434k)
Kuppusamy Karthik, SVP, Clinical Solutions
10b5-1 planSold 19.5% of holdings ($2.2M position)10,575 shares left1.4x usual sizeFollows a Form 144Filing
- 3 Form 144 notice DGXNoticeJul 30, 2025 +119 days
Filed to sell 8,269 shares ($1.4M)
Kuppusamy Karthik, Officer
10b5-1 plan4.4x usual sizeFiling
- 4 Form 144 notice DGXNoticeJul 31, 2025 +1 day
Filed to sell 2,210 shares ($376k)
Kuppusamy Karthik, Officer
10b5-1 plan1.2x usual sizeFiling
- 5 Form 4 sale DGXUnusualJul 31, 2025 same day
Sold 10,479 shares at $167.95 ($1.8M)
Kuppusamy Karthik, SVP, Clinical Solutions
10b5-1 planSold 55.4% of holdings ($3.2M position)8,450 shares left5.6x usual sizeFollows a Form 144Filing
- 6 Form 4 sale DGXNo planMar 4, 2026 +216 days
Sold 2,628 shares at $204.86 ($538k)
Kuppusamy Karthik, SVP, Clinical Solutions
No 10b5-1 planSold 16.4% of holdings ($3.3M position)13,441 shares left1.3x usual sizeFiling
- 7 Form 144 notice DGXNoticeJun 4, 2026 +92 days
Filed to sell 8,147 shares ($1.6M)
Kuppusamy Karthik, Officer
10b5-1 plan3.2x usual sizeFiling
- 8 Form 4 sale DGXUnusualJun 4, 2026 same day
Sold 8,147 shares at $200.00 ($1.6M)
Kuppusamy Karthik, SVP, Clinical Solutions
10b5-1 planSold 37.6% of holdings ($4.3M position)13,510 shares left3.2x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8, 2026 | DGX | SVP, Clinical Solutions | Form 4 sale | 8,147 | $1.6M | 37.6% | Unusual | SEC |
| Jun 4, 2026 | Jun 4, 2026 | DGX | Officer | Form 144 notice | 8,147 | $1.6M | Notice | SEC | |
| Mar 4, 2026 | Mar 6, 2026 | DGX | SVP, Clinical Solutions | Form 4 sale | 2,628 | $538k | 16.4% | No plan | SEC |
| Jul 31, 2025 | Aug 1, 2025 | DGX | SVP, Clinical Solutions | Form 4 sale | 10,479 | $1.8M | 55.4% | Unusual | SEC |
| Jul 31, 2025 | Jul 31, 2025 | DGX | Officer | Form 144 notice | 2,210 | $376k | Notice | SEC | |
| Jul 30, 2025 | Jul 30, 2025 | DGX | Officer | Form 144 notice | 8,269 | $1.4M | Notice | SEC | |
| Apr 2, 2025 | Apr 4, 2025 | DGX | SVP, Clinical Solutions | Form 4 sale | 2,555 | $434k | 19.5% | Routine | SEC |
| Apr 2, 2025 | Apr 2, 2025 | DGX | Officer | Form 144 notice | 2,555 | $434k | Notice | SEC | |
| Oct 28, 2024 | Oct 30, 2024 | DGX | SVP, Clinical Solutions | Form 4 sale | 1,775 | $279k | 15.4% | No plan | SEC |
| Oct 28, 2024 | Oct 28, 2024 | DGX | Officer | Form 144 notice | 1,775 | $278k | Notice | SEC | |
| Aug 28, 2024 | Aug 29, 2024 | DGX | SVP, Clinical Solutions | Form 4 sale | 1,990 | $305k | 14.8% | No plan | SEC |
| Aug 28, 2024 | Aug 28, 2024 | DGX | Officer | Form 144 notice | 1,990 | $305k | Notice | SEC | |
| Apr 29, 2024 | May 1, 2024 | DGX | SVP, Clinical Solutions | Form 4 sale | 1,760 | $246k | 11.6% | Routine | SEC |
| Apr 29, 2024 | Apr 29, 2024 | DGX | Officer | Form 144 notice | 1,760 | $246k | Notice | SEC |